None

Moot discusses advancements in nanotechnology

Palantir Technologies Inc PLTR shares are hitting new highs on Tuesday. Here’s a look at what’s going on . What To Know: Palantir shares are up more than 380% since the start of the year, driven largely by the company’s positioning in the AI space. The rally in Palantir shares accelerated at the beginning of November after the company reported strong quarterly results driven by “unrelenting” AI demand. Revenue jumped 30% year-over-year on continued strength in the U.S. and customer count grew 39% after the company closed 104 deals worth over $1 million during the quarter. “The growth of our business is accelerating, and our financial performance is exceeding expectations as we meet an unwavering demand for the most advanced artificial intelligence technologies from our U.S. government and commercial customers," Alex Karp , co-founder and CEO of Palantir, said in a letter to shareholders last month. Check This Out: Investors Aggressively Bought Stocks, ETFs In Volatile Fed Week: Bank Of America Reveals Largest Inflows Since 2017 Over the weekend, the Financial Times reported that Palantir and defense technology company Anduril are communicating with several competitors about the potential of forming a consortium to make a joint bid on U.S. government contracts. The report indicates that SpaceX and OpenAI are among the companies in talks to join. The group is planning to announce itself publicly as soon as January, people with knowledge of the matter said. "We are working together to provide a new generation of defense contractors," one person involved in organizing the group reportedly said. The Financial Times further reported that tie-ups between some tech groups expected to be involved with the consortium have already started. Palantir’s AI platform was integrated with Anduril’s autonomous software earlier this month and Anduril has linked its counter-drone systems with OpenAI models. Palantir announced last week that it extended its long-standing partnership with the U.S. Army through 2028. The four-year agreement extension is valued at more than $400 million and has a total available ceiling of approximately $619 million. By leveraging Palantir’s software, the U.S. Army is able to create AI-enabled data solutions to analyze information from multiple data sources, enabling operational efficiencies and optimizing business processes. PLTR Price Action: Palantir shares were trading at all-time highs at last check. The stock was up 1.31% at $81.79 at the time of publication Tuesday, according to Benzinga Pro . Photo: Shutterstock. © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.Why Dividend Investors Shouldn't Own DGRO

None

SMU has plenty to play for when it closes the regular season against California on Saturday afternoon in Dallas. The Mustangs (10-1, 7-0 Atlantic Coast Conference), who checked in at No. 9 in the latest College Football Playoff rankings on Tuesday, would like to send their seniors off the right way. They would also like to complete a perfect regular season before appearing in the ACC title game in their first year in the conference. Most importantly, they want to continue to strengthen their playoff case. "You've got the College Football Playoff, so every game matters. That's what's so cool about it now. The regular season is important," SMU coach Rhett Lashlee said. "We'd like to finish well in everything we do, particularly on Saturday, to finish off the regular season, continue our momentum into the following week. Hopefully, continue to show the committee and others that we're worthy of continuing to play this year." The Mustangs are a worthy playoff team to date. Kevin Jennings has established himself as one of the top quarterbacks in the country, throwing for 2,521 yards with 17 touchdowns and seven interceptions. He also has rushed for 315 yards and four TDs. Brashard Smith has been another standout, rushing for 1,089 yards and 13 TDs. Defensively, the Mustangs rank tied for 14th in the country with 20 takeaways. "Obviously they've had a phenomenal season," Cal coach Justin Wilcox said of SMU. "As soon as you turn the tape on, it doesn't take very long to see why their record is what it is. They're very, very good really in every phase of the game - extremely explosive and quick and fast. They've got a dominant D-line. We've got a lot of challenges in front of us and our guys are excited for that." Cal (6-5, 2-5) is coming off an emotional win, defeating rival Stanford 24-21 on Saturday to secure a bowl berth. The Golden Bears will appear in consecutive bowls for the first time since 2018-19 and are now looking to clinch their first winning season since 2019. SMU is not overlooking Cal, as all five of the Golden Bears' losses have come by one score. "You'd be hard-pressed to find a better 6-5 team in America," Lashlee said. "I think you can conservatively say they very, very easily could be 9-2." Cal is led by quarterback Fernando Mendoza, who has thrown for 3,004 yards with 16 touchdowns and six interceptions. Tight end Jack Endries leads the team with 555 yards receiving, while wide receiver Nyziah Hunter has caught a team-leading five touchdowns. Defensively, Cal has the ACC's top scoring defense (20.7 points per game) and is tied with Clemson for the ACC's best turnover margin (plus-13). Defensive back Nohl Williams is the star of the group -- he leads the country with seven interceptions. Even though oddsmakers are heavily favoring SMU, Cal is going into the game with a simple mindset. "Our task at hand is to make the best bowl game right now," Mendoza said. "And the way to do that is to go into Dallas, give it our best and ruin SMU's season." Saturday will mark the first conference meeting between these ACC newcomers, and just the second meeting between the programs all time. SMU won a 13-6 game back in 1957. --Field Level MediaNone

Kingsview Wealth Management LLC Takes $325,000 Position in NiSource Inc. (NYSE:NI)

My seven-year-old has been suspended TEN times – I’m terrified he’ll end up in prison

N.J. nursing home saga: America doesn’t care about its elderly | LetterAmerican Airlines has cut some international flights from major US airports next year and delayed others, blaming Boeing for the hold up. A number of new long-haul routes can’t go ahead yet because Boeing’s 787 Dreamliner jets are delayed, The Points Guy first reported . “As a result of ongoing Boeing 787 delivery delays, American is adjusting service on certain routes in spring 2025 to ensure we are able to re-accommodate customers on affected flights,” the airline said in a statement. “We’ll be proactively reaching out to our impacted customers to offer alternate travel arrangements and remain committed to mitigating the impact of these Boeing delays while continuing to offer a comprehensive global network.” American Airlines is awaiting delivery of 25 of the 787 Dreamline jets, according to Boeing orders and delivery figures . American Airlines services between Miami International Airport and Ministro Pistarini International Airport, near Buenos Aires, are being cut from three daily to two. Flights from Chicago O’Hare International Airport to Paris Charles De Gaulle have been on hold since September and won’t be restarting until May. They were scheduled to resume in April. At Miami, flights to the Parisian airport will be temporarily suspended in May. The airline stressed that routes to the destinations would not be canceled due to Boeing delays, but the flights would be starting later than planned. The Independent has contacted Boeing for comment. This morning American Airlines grounded its flights for around an hour across the U.S. on Christmas Eve amid one of the busiest travel periods of the year. The technology issue impacted systems needed to release flights, causing a ground stop that lasted approximately one hour. The Federal Aviation Administration (FAA) posted a nationwide groundstop order for all American flights at the request of the airline, an advisory notice shows, which has since been lifted. Passengers aired their woes on social media about the delays to their Christmas Eve travel plans due to the temporary halting of American Airlines flights. One X user wrote that they had been required to deplane at Pittsburgh International Airport, to which the airline responded: “We’re doing our best to get things back on track. Please accept our sincere apologies for any inconvenience this has caused.” Another passenger wrote: “Heck of way to start Christmas. Hey, American Airlines just tell us whether we should go home or not. Please don’t make us wait in the airport for hours.” A video posted from Fort Lauderdale-Hollywood International Airport showed a large crowd waiting in the gate area with an announcer saying that its “system is down” so they could not get the crew on the plane nor board any customers. FlightRadar24, a flight data tracking site, said on X that while the ground stop has now been canceled, “it will take some time for flights to get back to normal.” It added that there are 420 active American Airlines flights as of 8:32 a.m., whereas at the same time last week, there were 620.Public service enterprise group president sells $86,115 in stock

Hunter Sallis poured in 31 points and Wake Forest needed most of those in a 67-57 home victory against Detroit Mercy on Saturday at Winston-Salem, N.C. Davin Cosby had 11 points as the Demon Deacons (6-1) won their second straight since their only loss, which came a week earlier at Xavier. But it wasn't easy as the visiting Titans (3-3) were persistent as they trimmed a 19-point deficit to nine points with plenty of time remaining (5:54). Orlando Lovejoy led the Titans with 15 points and TJ Nadeau had 13 points and nine rebounds off the Detroit Mercy bench despite shooting 1-for-8 on 3-pointers. Jared Lary added 10 points. Wake Forest doubled up the Titans in 3-point production by making 10 compared to Detroit Mercy's five. But the Demon Deacons took more than half of their attempts (61) from beyond the 3-point arc (35). As a result, they were just 9-for-13 on free throws. The Titans also held a 48-31 advantage in rebounding. Some of that might have been attributed to the absence of Wake Forest center Efton Reid III, who has been dealing with migraines. Detroit Mercy trailed 36-23 at halftime, but Wake Forest couldn't put the Titans away. Sallis shot 12-for-18 from the field and made five 3-point shots. He ended up two points shy of his career-high mark. Sallis came through with clutch shots, including a 3-pointer to go up by 12 with 4:59 left. Cosby had three 3-pointers before hitting his lone 2-point basket with 3:33 left to push the lead back to 14. The Titans shot only 5-for-19 on 3-pointers and they checked in at 33.3 percent overall from the field. Detroit Mercy was charged with 14 turnovers compared to only five for Wake Forest. Detroit Mercy was coming off Wednesday night's victory at Ball State. That outcome marked the team's first true road triumph since February 2023, but the Titans couldn't duplicate it. --Field Level MediaGlobal Media Congress 2024: Transforming Media Paradigms

Bruce Willis ' family is praying for a miracle amid his battle with dementia this Christmas. In spite of his fight with frontotemporal dementia, Bruce Willis' family is getting ready for a meaningful Christmas celebration. ET Year-end Special Reads Top 10 equity mutual funds of the year. Do you have any? How India flexed its global power muscles in 2024 2024 was the year India became the talk of America According to reports, the family of the Hollywood star intends to document special moments with pictures and videos before the actor's 70th birthday in March. As they support the actor, Bruce Willis' family maintains hope despite obstacles in his fight with dementia. The 69-year-old celebrity, whose dementia diagnosis was revealed in 2023, will spend the holidays with his family's love and support. According to reports, his ex-wife Demi Moore and their daughters Rumer, 36; Scout, 33; and Tallulah, 30 will be joining his wife, Emma Heming Willis, and their daughters Mabel, 12, and Evelyn, 10 during the holiday season. The family is uniting to make this Christmas extra special as they continue to pray for a miracle and hope for a medical breakthrough, as quoted in a report by In Touch. The family is mostly focused on spending quality time with him while they still can, and every second of connection with him is special. The family intends to strengthen their bonds by listening to music and looking at old photos and videos. They love coming together as a family. Artificial Intelligence(AI) ChatGPT Mastery from Zero to Hero: The Complete AI Course By - Metla Sudha Sekhar, IT Specialist and Developer View Program Office Productivity Mastering Microsoft Office: Word, Excel, PowerPoint, and 365 By - Metla Sudha Sekhar, IT Specialist and Developer View Program Marketing Digital Marketing Masterclass by Pam Moore By - Pam Moore, Digital Transformation and Social Media Expert View Program Office Productivity Advanced Excel Course - Financial Calculations & Excel Made Easy By - Anirudh Saraf, Founder- Saraf A & Associates, Chartered Accountant View Program Web Development A Comprehensive ASP.NET Core MVC 6 Project Guide for 2024 By - Metla Sudha Sekhar, IT Specialist and Developer View Program Office Productivity Microsoft Word Mastery: From Beginner to Expert By - CA Raj K Agrawal, Chartered Accountant View Program Web Development Intermediate C++ Skills: Master Pointers, Structures and File Stream By - Metla Sudha Sekhar, IT Specialist and Developer View Program Office Productivity Mastering Google Sheets: Unleash the Power of Excel and Advance Analysis By - Metla Sudha Sekhar, IT Specialist and Developer View Program Artificial Intelligence(AI) Master in Python Language Quickly Using the ChatGPT Open AI By - Metla Sudha Sekhar, IT Specialist and Developer View Program Artificial Intelligence(AI) AI for Everyone: Understanding and Applying the Basics on Artificial Intelligence By - Ritesh Vajariya, Generative AI Expert View Program Data Science SQL Server Bootcamp 2024: Transform from Beginner to Pro By - Metla Sudha Sekhar, IT Specialist and Developer View Program Data Science SQL for Data Science along with Data Analytics and Data Visualization By - Metla Sudha Sekhar, IT Specialist and Developer View Program Artificial Intelligence(AI) AI-Powered Python Mastery with Tabnine: Boost Your Coding Skills By - Metla Sudha Sekhar, IT Specialist and Developer View Program Leadership Business Storytelling Masterclass By - Ameen Haque, Founder of Storywallahs View Program Entrepreneurship From Idea to Product: A Startup Development Guide By - Dr. Anu Khanchandani, Startup Coach with more than 25 years of experience View Program Design Microsoft Designer Guide: The Ultimate AI Design Tool By - Prince Patni, Software Developer (BI, Data Science) View Program Artificial Intelligence(AI) Tabnine AI Masterclass: Optimize Your Coding Efficiency By - Metla Sudha Sekhar, IT Specialist and Developer View Program Artificial Intelligence(AI) Learn InVideo AI: Create Videos from Text Easily By - Prince Patni, Software Developer (BI, Data Science) View Program Entrepreneurship Startup Fundraising: Essential Tactics for Securing Capital By - Dr. Anu Khanchandani, Startup Coach with more than 25 years of experience View Program Artificial Intelligence(AI) Generative AI for Dynamic Java Web Applications with ChatGPT By - Metla Sudha Sekhar, IT Specialist and Developer View Program Finance Financial Literacy for Non-Finance Executives By - CA Raja, Chartered Accountant | Financial Management Educator | Former AVP - Credit, SBI View Program Artificial Intelligence(AI) AI and Analytics based Business Strategy By - Tanusree De, Managing Director- Accenture Technology Lead, Trustworthy AI Center of Excellence: ATCI View Program Entrepreneurship Building Your Winning Startup Team: Key Strategies for Success By - Dr. Anu Khanchandani, Startup Coach with more than 25 years of experience View Program Finance Tally Prime & GST Accounting: Complete Guide By - CA Raj K Agrawal, Chartered Accountant View Program Demi Moore said it is very difficult to see her ex-husband struggle, but she believes it is important for anyone dealing with this to meet them where they are at, and from that place, there is such loving and joy. FAQs How does Bruce Willis' family support him during his dementia battle? The family is focusing on spending quality time together, sharing photos, videos, and music to preserve memories and strengthen their bond. What plans do the family have for the holidays and Bruce's 70th birthday? They plan a special Christmas celebration and will commemorate Bruce's 70th birthday in March by sharing heartfelt memories and spreading joy. (You can now subscribe to our Economic Times WhatsApp channel )

NoneChargers will be without top RB Dobbins and could lean on QB Herbert against Falcons

Global Nephropathic Cystinosis Treatment Market to Surpass US$ 744.3 Million by 2034 | TMR Analysis 12-24-2024 04:50 PM CET | Health & Medicine Press release from: Transparency Market Research The global nephropathic cystinosis treatment market, which was valued at US$ 332.5 million in 2023, is projected to grow at a compound annual growth rate (CAGR) of 7.4%, reaching US$ 744.3 million by 2034, according to the latest market analysis. This promising growth trajectory highlights significant advancements in treatment options and rising awareness about this rare genetic disorder. Access an overview of significant conclusions from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=32210 Market Overview Nephropathic cystinosis is a rare lysosomal storage disorder characterized by the accumulation of cystine in various organs, leading to progressive kidney damage and other systemic complications. The increasing focus on improving early diagnosis and the availability of advanced therapeutic solutions are expected to drive market growth over the forecast period. The market is segmented based on treatment type (drugs and renal transplant) and treatment availability (medication and surgery). While medications remain the cornerstone of treatment, renal transplants are often required for advanced cases, offering a critical solution to patients with end-stage renal disease. Key Drivers 1.Advancements in Therapeutics: Ongoing research and development efforts have led to the introduction of innovative drugs designed to delay disease progression and improve the quality of life for patients. The availability of cysteamine-based therapies, such as delayed-release capsules and oral solutions, has significantly improved treatment adherence and outcomes. 2.Increasing Awareness and Diagnosis Rates: Public and private initiatives aimed at raising awareness about nephropathic cystinosis are contributing to earlier diagnoses and timely interventions. This is particularly significant in regions where genetic screening programs are being implemented. 3.Rising Healthcare Expenditure: Increased healthcare spending, particularly in emerging economies, is enhancing access to advanced treatment options and specialized care for rare diseases, including nephropathic cystinosis. Market Challenges and Opportunities While the market outlook is positive, several challenges persist: •High Cost of Treatment: The expensive nature of drugs and renal transplantation procedures can limit access, especially in low-income countries. •Limited Patient Population: As a rare disease, nephropathic cystinosis has a small patient base, which poses challenges for large-scale commercialization of treatments. However, these challenges also present opportunities for innovation. Pharmaceutical companies are focusing on developing cost-effective and patient-friendly treatment modalities, such as improved formulations of cysteamine and potential gene therapies. Visit our report to explore the detailed insights and key takeaways - https://www.transparencymarketresearch.com/nephropathic-cystinosis-treatment-market.html Regional Analysis The market exhibits significant regional variations: •North America dominates the global market, owing to robust healthcare infrastructure, high awareness levels, and ongoing research initiatives. •Europe holds a substantial share, driven by government support for rare disease treatment and well-established diagnostic facilities. •Asia Pacific is anticipated to witness the fastest growth, fueled by increasing healthcare investments and rising awareness in emerging economies like China and India. •Other regions, including Latin America and the Middle East & Africa, are gradually improving access to specialized treatments through international collaborations and policy initiatives. Market Segmentation The market is primarily categorized into two segments: •Treatment Type: oDrugs: Oral and delayed-release formulations of cysteamine remain the standard of care. oRenal Transplant: Critical for advanced cases, with demand increasing as the patient population ages. •Treatment Availability: oMedication: Widely available and accessible, particularly in developed nations. oSurgery: Renal transplants are less common but essential for severe cases. Future Outlook The nephropathic cystinosis treatment market is poised for significant growth over the next decade. Innovations in therapeutic approaches, coupled with increasing global efforts to improve diagnosis and management, are likely to reshape the market landscape. The advent of gene editing technologies and targeted therapies may revolutionize treatment paradigms, offering hope for a potential cure. Companies Profiled Several leading players are contributing to the growth of the nephropathic cystinosis treatment market, including: Amgen Inc., Recordati Rare Diseases, Chiesi Farmaceutici S.p.A., Eloxx Pharmaceuticals Inc., Viatris Inc. (Mylan) These companies are actively investing in research and development to introduce novel therapies and expand their presence in emerging markets. Explore Latest Research Reports by Transparency Market Research: Paresthesia Treatment Market: https://www.transparencymarketresearch.com/paresthesia-treatment-market.html PCSK9 Inhibitor Market: https://www.transparencymarketresearch.com/pcsk9-inhibitors-market.html About Transparency Market Research Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact: Transparency Market Research Inc. CORPORATE HEADQUARTER DOWNTOWN, 1000 N. West Street, Suite 1200, Wilmington, Delaware 19801 USA Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Website: https://www.transparencymarketresearch.com Email: sales@transparencymarketresearch.com Follow Us: LinkedIn| Twitter| Blog | YouTube This release was published on openPR.The AP Top 25 men’s college basketball poll is back every week throughout the season! Get the poll delivered straight to your inbox with AP Top 25 Poll Alerts. Sign up here . UNCASVILLE, Conn. (AP) — (AP) — Nick Fiorillo’s 20 points helped Vermont defeat Delaware 75-71 on Saturday. Fiorillo also contributed eight rebounds for the Catamounts (3-3). Shamir Bogues scored 18 points while finishing 8 of 11 from the floor and added six rebounds and three steals. TJ Hurley shot 4 of 12 from the field, including 1 for 7 from 3-point range, and went 5 for 6 from the line to finish with 14 points. Izaiah Pasha led the way for the Fightin’ Blue Hens (2-3) with 20 points. John Camden added 19 points for Delaware. Cavan Reilly also had 18 points. ___ The Associated Press created this story using technology provided by Data Skrive and data from Sportradar .Police deny sitting on evidence as Netflix doc brings renewed attention to JonBenet Ramsey's killing

Chargers will be without top RB Dobbins and could lean on QB Herbert against Falcons

Hunter Sallis poured in 31 points and Wake Forest needed most of those in a 67-57 home victory against Detroit Mercy on Saturday at Winston-Salem, N.C. Davin Cosby had 11 points as the Demon Deacons (6-1) won their second straight since their only loss, which came a week earlier at Xavier. But it wasn't easy as the visiting Titans (3-3) were persistent as they trimmed a 19-point deficit to nine points with plenty of time remaining (5:54). Orlando Lovejoy led the Titans with 15 points and TJ Nadeau had 13 points and nine rebounds off the Detroit Mercy bench despite shooting 1-for-8 on 3-pointers. Jared Lary added 10 points. Wake Forest doubled up the Titans in 3-point production by making 10 compared to Detroit Mercy's five. But the Demon Deacons took more than half of their attempts (61) from beyond the 3-point arc (35). As a result, they were just 9-for-13 on free throws. The Titans also held a 48-31 advantage in rebounding. Some of that might have been attributed to the absence of Wake Forest center Efton Reid III, who has been dealing with migraines. Detroit Mercy trailed 36-23 at halftime, but Wake Forest couldn't put the Titans away. Sallis shot 12-for-18 from the field and made five 3-point shots. He ended up two points shy of his career-high mark. Sallis came through with clutch shots, including a 3-pointer to go up by 12 with 4:59 left. Cosby had three 3-pointers before hitting his lone 2-point basket with 3:33 left to push the lead back to 14. The Titans shot only 5-for-19 on 3-pointers and they checked in at 33.3 percent overall from the field. Detroit Mercy was charged with 14 turnovers compared to only five for Wake Forest. Detroit Mercy was coming off Wednesday night's victory at Ball State. That outcome marked the team's first true road triumph since February 2023, but the Titans couldn't duplicate it. --Field Level Media